These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 1686330)

  • 1. [Simultaneous assay of SLX and CEA does not increase the clinical usefulness of the latter in patients with colorectal carcinoma].
    Roiz MC; Allende MT; Vivanco J; Ruibal A
    Rev Clin Esp; 1991 Mar; 188(5):266-7. PubMed ID: 1686330
    [No Abstract]   [Full Text] [Related]  

  • 2. Serological studies on CEA, CA 19-9, STn and SLX in colorectal cancer.
    Sato T; Nishimura G; Nonomura A; Miwa K; Miyazaki I
    Hepatogastroenterology; 1999; 46(26):914-9. PubMed ID: 10370638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Gallbladder carcinoma producing CEA, AFP, CA19-9, sialyl SSEA and CSF].
    Tanigawa N
    Ryoikibetsu Shokogun Shirizu; 1996; (9):237-9. PubMed ID: 8705462
    [No Abstract]   [Full Text] [Related]  

  • 4. Tumour markers: from carcinoembryonic antigen to products of hybridoma technology.
    Begent R; Rustin GJ
    Cancer Surv; 1989; 8(1):107-21. PubMed ID: 2680066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The usefulness of determining carcinoembryonic antigen in the bile for the prognosis of the development of hepatic metastases following the resection of colorectal cancer].
    de Andrés García B; Piñero Madrona A; Pérez Ayala M; Parrila Paricio P
    Med Clin (Barc); 1997 Mar; 108(10):396. PubMed ID: 9139148
    [No Abstract]   [Full Text] [Related]  

  • 6. [Expression of tumor-associated antigen LEA and its significance for pathological diagnosis].
    Feng H; Song JD
    Ai Zheng; 2002 Jun; 21(6):658-62. PubMed ID: 12452070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Follow-up after colorectal cancer. Undeserved neglect of CEA-analysis].
    Børmer OP
    Tidsskr Nor Laegeforen; 1998 Aug; 118(18):2825-6. PubMed ID: 9748821
    [No Abstract]   [Full Text] [Related]  

  • 8. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.
    Guadagni F; Kantor J; Aloe S; Carone MD; Spila A; D'Alessandro R; Abbolito MR; Cosimelli M; Graziano F; Carboni F; Carlini S; Perri P; Sciarretta F; Greiner JW; Kashmiri SV; Steinberg SM; Roselli M; Schlom J
    Cancer Res; 2001 Mar; 61(6):2523-32. PubMed ID: 11289125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The value of tumor markers in colorectal cancer].
    Peters KM; Grundmann R
    Leber Magen Darm; 1989 Jan; 19(1):18-25. PubMed ID: 2927234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Tumor markers for lung neoplasm].
    Sekido Y
    Nihon Rinsho; 2002 May; 60 Suppl 5():229-32. PubMed ID: 12101663
    [No Abstract]   [Full Text] [Related]  

  • 11. Significance of CA72.4 in patients with colorectal cancer. Comparison with CEA and CA19.9.
    Filella X; Molina R; Mengual PJ; Jo J; Ballesta AM
    J Nucl Biol Med (1991); 1991; 35(3):158-61. PubMed ID: 1816871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New clinical tests: current status of tumor markers].
    Imai K; Taniuchi A
    Nihon Naika Gakkai Zasshi; 1993 Apr; 82(4):554-7. PubMed ID: 7688018
    [No Abstract]   [Full Text] [Related]  

  • 13. [Tissue carcinoembryonic antigen: a screening test for increased cell proliferation?].
    Rosandić-Pilas M; Hadzić N; Stavljenić A; Juricić M; Sćukanec-Spoljar M
    Lijec Vjesn; 1989 Aug; 111(8):249-53. PubMed ID: 2811584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antigens (CEA and CA 19-9) in diagnosis and prognosis colorectal cancer].
    Grotowski M
    Pol Merkur Lekarski; 2002 Jan; 12(67):77-80. PubMed ID: 11957811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Usefulness of preoperative assay CEA and CA 19-9 in colorectal cancer patients].
    Grotowski M; Maruszyński M; Piechota W
    Pol Merkur Lekarski; 2001 Dec; 11(66):476-9. PubMed ID: 11899841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The importance of monitoring colorectal adenomas by tumor markers (ROC analysis).
    Stajic S; Novaković R; Kostić N; Josifovski J; Simić P; Katić V; Kovijanić M
    Med Pregl; 1993; 46 Suppl 1():69-71. PubMed ID: 8569613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tumor markers in gastrointestinal cancer and its clinical significance].
    Taguchi T; Ota J; Sumida S; Rii M
    Gan To Kagaku Ryoho; 1987 Nov; 14(11):3004-9. PubMed ID: 3479051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carcinoembryonic antigen and CA19-9: implications of quantitative marker measurement in tissues for prognosis of colorectal cancer.
    Gebauer G; Müller-Ruchholtz W
    Cancer Detect Prev; 2001; 25(4):344-51. PubMed ID: 11531011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calretinin, thrombomodulin, CEA, and CD15: a useful combination of immunohistochemical markers for differentiating pleural epithelial mesothelioma from peripheral pulmonary adenocarcinoma.
    Comin CE; Novelli L; Boddi V; Paglierani M; Dini S
    Hum Pathol; 2001 May; 32(5):529-36. PubMed ID: 11381372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical evaluation of a combination assay of CEA, CA-19-9 and TPA in patients with colorectal cancer].
    Nishida O; Shiroto H; Satoh N; Nakajima Y; Manabe K; Kondoh Y; Sano F; Uchino J
    Gan No Rinsho; 1988 Aug; 34(9):1096-100. PubMed ID: 3172515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.